2024
Immune checkpoint inhibitors in high‐grade upper tract urothelial carcinoma: Paradigm shift emphasizing organ preservation
Khalil M, Fishman A, Komorowski A, Franco I, Grasso M. Immune checkpoint inhibitors in high‐grade upper tract urothelial carcinoma: Paradigm shift emphasizing organ preservation. BJUI Compass 2024, 5: 604-610. PMID: 38751949, PMCID: PMC11090768, DOI: 10.1002/bco2.335.Peer-Reviewed Original ResearchImmune check point inhibitorsHigh-grade upper tract urothelial carcinomaUpper tract urothelial carcinomaMetastasis-free survival ratesGroup 2Group 1Survival rateUrothelial carcinomaSurvival outcomesMedian follow-up periodImpact of clinical characteristicsCheck-point inhibitorsImmune checkpoint inhibitorsEndoscopically treated patientsInitial tumor sizeImprove survival outcomesOverall survival rateKaplan-Meier analysisFollow-up periodImproved survival ratesCheckpoint inhibitorsPoint inhibitorsExtirpative surgeryTumor sizeClinical characteristics
2019
Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology
Roberts J, Ghali F, Aganovic L, Bechis S, Healy K, Rivera-Sanfeliz G, Autorino R, Derweesh I. Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology. Abdominal Radiology 2019, 44: 3893-3905. PMID: 31701194, DOI: 10.1007/s00261-019-02293-9.Peer-Reviewed Original ResearchConceptsUpper tract urothelial carcinomaUrothelial carcinomaDevelopment of UTUCPost-operative surveillanceRadical extirpative surgeryHigh recurrence rateSpecific clinical situationsMorbid therapyInvasive workupUrothelial malignancyRecurrence rateExtirpative surgeryLethal malignancyNew patientsInvasive proceduresClinical situationsEndoscopic surgeryEnvironmental exposuresDiagnosisPatientsSurgeryCarcinomaMalignancyWorkupClose working relationship
2009
Surgery does not adversely affect survival in primary gastrointestinal lymphoma
Cheung MC, Housri N, Ogilvie MP, Sola JE, Koniaris LG. Surgery does not adversely affect survival in primary gastrointestinal lymphoma. Journal Of Surgical Oncology 2009, 100: 59-64. PMID: 19399785, DOI: 10.1002/jso.21298.Peer-Reviewed Original ResearchConceptsGastrointestinal lymphomaMultivariate analysisMarginal zone B-cell lymphomaAssociated survival benefitPrimary gastrointestinal lymphomaEnd Results (SEER) databaseImpact of surgeryRisk of deathB-cell lymphomaMedian survivalOverall survivalSurgical resectionIndependent predictorsSurvival benefitOverall incidencePoor prognosisResults databaseSurgical extirpationExtirpative surgeryTumor locationMale genderUnivariate analysisSurgeryLymphomaTreatment data
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply